Patient Intake Assistant

Note: This analysis is based entirely on the self-reported project description provided by the caller. No external verification or historical data is available. All statements are labeled as "the author states" unless otherwise noted.

The author states that the product is an AI intake assistant that interviews patients before their visit and gives doctors a structured, verifiable summary.

• The system uses GPT-5.6 mini for conversation logic.
• It includes a FastAPI backend, React frontend, Supabase for auth/database/storage.
• The chat loop is designed to ensure all nine intake topics are covered before closing the interview.
• Emergency open questions are handled via pre-model rules, not the language model.
• The system supports returning patients by referencing past intake summaries.
• It generates PDF reports for doctors.

Inference: Based on the author's own description, this is a prototype built in a short timeframe (likely a hackathon project) with no evidence of commercial deployment or production use beyond the author’s own testing.

The author states that the idea came from a conversation at a tech event where a doctor expressed frustration over time spent gathering patient information during appointments.

• The product is positioned as a way to move intake questions before the visit, so doctors walk in with a summary.
• It claims to reduce time wasted on basic information-gathering and improve efficiency for physicians.
• The author emphasizes safety by keeping critical logic outside of the LLM.

Claim vs Fact: These are self-reported claims about intent and positioning. There is no evidence that this has been validated in practice or adopted by real users.

The author states that the primary user is a doctor who sees patients and wants to save time during visits.

• The system targets physicians who perform frequent patient intake, especially those switching between surgeries and appointments.
• It also implies a secondary audience: patients who will interact with the assistant via chat before their visit.

Inference: The ICP appears to be healthcare providers (doctors) using an AI tool to streamline pre-appointment information gathering. No evidence of segmentation or targeting beyond this general group.

Not evidenced.

The description does not contain any information about pricing, monetization strategy, or business model.

Absence of evidence: There is no mention of how the product would be sold, who pays for it, or what revenue streams are envisioned.

The author states that they built the system in phases:

• Chat loop first
• Then persistence
• Then authentication
• Then doctor-side dashboard

Key technical decisions include:

• Use of GPT-5.6 mini due to latency concerns.
• Codex used for debugging and test case generation.
• Server controls when the interview ends, not the model.
• Emergency open questions enforced by code, not LLM.
• State management issues fixed with database constraints and row-level security.

Inference: The author shows engineering discipline in handling state, access control, and safety logic. However, this is a solo-built prototype, not a scalable product.

Not evidenced.

There is no mention of:

• Customers
• Revenue
• Usage metrics
• Product adoption
• User feedback or testing

Absence of evidence: No traction data exists in the description. The project is described as a hackathon submission with no indication of real-world use.

Not evidenced.

The description does not reference any competitors, market size, or competitive landscape.

Absence of evidence: No information on existing solutions or how this compares to other tools in healthcare intake or AI assistant platforms.

• Solo-built prototype: The system was built by two individuals (as stated), likely without a dedicated team or product development process.
• No commercialization plan: There is no indication of a go-to-market strategy, pricing model, or customer acquisition approach.
• Unverified safety claims: While the author emphasizes safety logic being outside the LLM, there’s no evidence that these safeguards have been tested in real-world conditions.
• Limited scalability assumptions: The architecture seems tailored for a small-scale prototype, not enterprise-level deployment.

Inference: This is a proof-of-concept with no clear path to commercial viability or long-term sustainability.

1. What specific feedback did you get from the doctor who inspired this idea?
2. Have you tested the system with actual patients and doctors in a live setting?
3. How do you plan to scale beyond the current prototype?
4. Are there any regulatory or compliance considerations for healthcare data that you’ve addressed?
5. What is your roadmap for monetization and customer acquisition?
6. How do you intend to handle integration with existing EMR systems?